Table 1 Comparison of clinical characteristics between the frailty and non-frailty groups.
Variable | All patients | Frailty | Non-frailty | p-value |
|---|---|---|---|---|
Patients, n (%) | 189 | 70 (37.0) | 119 (63.0) | |
Men/Women | 121/68 | 37/33 | 84/35 | 0.014 |
Age (years) | 70.0 (59.0–77.5) | 76.0 (69.0–80.0) | 66.0 (57.0–73.0) | < 0.001 |
Etiology | ||||
HBV/HCV/alcohol/others, n | 18/58/61/52 | 7/27/15/21 | 11/31/46/31 | 0.087 |
Decompensated cirrhosis, n (%) | 64 (33.9) | 32 (45.7) | 32 (26.9) | 0.008 |
Child–Pugh score | 6 (5–7) | 6 (5–8) | 6 (5–7) | 0.035 |
MELD score | 8 (7–11) | 9 (7–12) | 8 (7–10) | 0.361 |
Total bilirubin (mg/dL) | 0.8 (0.6–1.3) | 0.8 (0.6–1.4) | 0.9 (0.6–1.3) | 0.836 |
Albumin (g/dL) | 3.7 (3.2–4.1) | 3.6 (3.1–4.0) | 3.8 (3.4–4.1) | 0.043 |
Creatinine (mg/dL) | 0.9 (0.7–1.1) | 0.9 (0.7–1.1) | 0.8 (0.7–1.1) | 0.929 |
Prothrombin time (%) | 78 (62–92) | 77 (58–93) | 78 (63–93) | 0.495 |
M2BPGi (C.O.I.) | 3.08 (1.55–5.72) | 3.52 (1.59–6.30) | 2.74 (1.43–5.54) | 0.174 |
Osteoporosis, n (%) | 61 (32.3) | 41 (58.6) | 20 (16.8) | < 0.001 |
HCC, n (%) | 26 (13.8) | 13 (18.6) | 13 (10.9) | 0.141 |
